Erwacht Isonics aus dem Dornröschenschlaf - 500 Beiträge pro Seite

[Aktientiger]

Diese Frage muß man sich stellen, wenn man die Umsätze in den letzten Monaten an der Nasdaq verfolgt hat.
Seit ein paar Tagen ziehen die Umsätze an. Sicher noch nicht die Welt, aber vielleicht die ersten Vorboten für Neuigkeiten.
Belasten dürft den Kurs sicherlich noch der anstehende Rechtstreit (bzw. Anhörung) mit Eagle Picher.
Isonics hat EP auf ca 70 Mio USD Schadensersatz veklagt, EP umgekehrt Isonics auf ca. 10 Mio USD. Würde EP gewinne, wäre das sicherlich das Aus für Isonics.
Gewinn Isonics, oder man vergleicht sich, und kommt dann noch der Erfolg des Geschäftsmodells hinzu, könnte der Aktie eine interessante Performance bevorstehen.

Weiter Infos sicherlich auf der Hompage von Isonics nachzulesen: www.isonics.com

(Für die Darstellung des Rechtstreites lege ich nicht meine HAnd ins Feuer, gebe dass wieder, was ich laienhaft verstanden habe.)

[Aktientiger]

Isonics legr 10Q vor!

Verlustredukiton auf 0,06 USD gegenüber 0,28 USD im 3Q 2001!!
(Wenn ich das richtig verstanden habe)

Der Schuldenberg wächst somit nur noch langsam auf ca. 9 Mio USD an. Das sollt man bei Erfolg des Geschäftsmodells locker abtragen können.

Heißt,dass das ISonics Geld verdient?!


Gruß an alle Isonis-Fans

www.edgaronline.com
www.knobias.com

[Aktientiger]

Kann nicht glauben, dass diese nette Kurssteigerung nur durch diesen 1oQ Bericht augelöst wird.
Ist da noch mehr im Bush.
Denn schließlich, schreibt Isonics, dass das working capital für (nur) wahrscheinlich zwei Monate gesichert ist.
Also, was tut sich noch.
Gebe zu habe den 10 Q aber nur überflogen und Wichtiges vielleicht überlesen.

Sieht und Weiß jemand mehr?

[Gunsi]

Moing,

Schaut mal hier rein..

http://www.semiseeknews.com/press_release3015.htm

Gruß Gunsi

[Aktientiger]

Es gibt Neuigkeiten:
Monday March 25, 8:43 am Eastern Time
Press Release
SOURCE: Isonics Corporation
Isonics Corporation Closes $1 Million Private Placement
GOLDEN, Colo.--(BUSINESS WIRE)--March 25, 2002--Isonics Corporation (Nasdaq:ISON - news) a leader in the development of isotopically engineered semiconductor materials and a supplier of silicon-on-insulator wafers and isotopes for life sciences and health care applications, has announced that the company has closed a $1 million private placement with a small number of accredited investors.

``This $1 million private placement will allow Isonics to continue its plan which we believe will allow us to achieve profitability by our quarter ending January 31, 2003,`` said James E. Alexander, Chairman & CEO for Isonics Corporation. ``Unless we decide to undertake an acquisition, it is unlikely we will need to obtain further financing this year. With this out of the way, we can focus on growing our life sciences business, continue to penetrate the silicon-on-insulator wafer market, and respond to the increasing level of customer interest we are seeing for high thermal conductivity silicon-28.``

Isonics has recently become a supplier of silicon-on-insulator wafers (SOI) via a previously announced manufacturing alliance utilizing technology obtained from Silicon Evolution, Inc. in 2001. SOI wafers are the fastest growing segment of the $6 to 7 billion silicon wafer market. Silicon-28 is a highly purified form of silicon which has greater ability to dissipate heat than normal silicon used to make virtually all semiconductor devices manufactured today. Isonics has the exclusive rights to key patents covering silicon-28 and has been providing evaluation wafers to major semiconductor manufacturers. Isonics believes that the combination of silicon-28 and the SOI wafer structure will be quite desirable in certain product applications.

This placement was structured as 4% convertible notes and warrants. The notes are convertible into registered Isonics common stock at the option of either the note holder or Isonics at $1.00 per share. Isonics may also repay the principle in cash plus accrued interest at its option. The noteholders were issued 1 five-year warrant exercisable at $1.25 for a share of common stock for every $5 in principle loaned. The warrants may only be exercised for cash. Neither the notes nor the warrants provide for any re-set in conversion or exercise prices (except for normal dilution adjustment) unless Isonics were to sell common stock at less than $1.00 per share in the six months following closing of this placement. Further details will be provided in the Form 8-K to be filed with the SEC.

ABOUT ISONICS CORPORATION - Isonics is a world leader in isotopically engineered materials and produces isotopically pure silicon-28 chemicals and wafers and silicon-on-insulator wafers (SOI) for the semiconductor industry. Isonics also markets and sells stable isotopes for the health care industry such as carbon-13 for diagnostic breath tests and drug design, and oxygen-18 for positron emission tomography (PET) imaging. Stable isotopes can be thought of as ultra pure materials. For additional information visit http://www.isonics.com.

Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company`s actual results or outcomes to be materially different from those anticipated and discussed herein, and which may result in the parties being unable or unwilling to complete the transaction described herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company`s control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company`s 10-KSB for the year ended April 30, 2001 as filed with the Securities and Exchange Commission, which include the Company`s cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company`s filings with the Securities and Exchange Commission.



--------------------------------------------------------------------------------

[Aktientiger]

Es gibt wieder Neuigkeiten.
Schade, dass sich fast niemand für diesen Wert zu interessieren scheint.
Isonics geht doch ganz zielstrebig seinen Weg.


Gruß an alle verbliebenen Isonics-Fans!

[MartinRR]

@ Aktientiger:

Bin noch da! Was gibt`s denn Neues? Link / Kopie im Thread? Danke!

Grüße, MartinRR

[Aktientiger]

Hallo MartinRR,

schaue auf den neuen Thread unter diesem Thread!

Wird doch eine spannnende Sache,oder ?



Gruß

Aktientiger